- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Wearable Patient Monitoring Tested at Penn Medicine
The University of Pennsylvania Health System just began its three-week pilot of continuous, wearable patient monitoring. If effective, this could significantly decrease the labor that nurses are required to undertake to care for patients.
The University of Pennsylvania Health System just began its three-week pilot of continuous, wearable patient monitoring. If effective, this could significantly decrease the labor that nurses are required to undertake to care for patients.
According to the article on MedCityNews:
Monday, Penn Medicine launched a small-scale test of a wearable vitals monitor in a medical-surgical unit for cancer patients, Associate CIO Jim Beinlich confirmed to MedCity News. He said he was not allowed to name the technology vendor, but he said the monitors are FDA-approved hospital products, not consumer devices, and are worn on the arm.
The pilot is intended to be a proof of concept to see whether clinicians and patients like the monitors.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.